SARS-CoV-2 Omicron Spike RBD Protein Biotinylated
Catalog Number: B2010591 (50 ug)
SARS-CoV-2 Omicron Spike RBD Protein Biotinylated is a highly pure biotinylated recombinant SARS-CoV-2 Spike RBD of the Omicron (B.1.1.529) variant. This product has been used as molecular component of various serological and antigenic assays for SARS-CoV-2 and its variants. It has also been used in a wide array of other biochemical and immunological applications. Custom bulk amounts of this product are available upon request.
Live enquiry about this product via Text/SMS: 1-858-900-3210.
Product Description
SARS-CoV-2 Omicron Spike RBD Protein Biotinylated
Catalog number: B2010591
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 ug
Molecular Weight or Concentration: 30 kDa
Supplied as: Liquid
Applications: molecular component of various serological and antigenic assays for SARS-CoV-2 and its variants
Storage: -20C
Keywords: SARS-CoV-2 B.1.1.529, Omicron RBD, Omicron Spike
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Giovanetti M, Benedetti F, Campisi G, Ciccozzi A, Fabris S, Ceccarelli G,
Tambone V, Caruso A, Angeletti S, Zella D, Ciccozzi M. Evolution patterns of
SARS-CoV-2: Snapshot on its genome variants. Biochem Biophys Res Commun. 2021
Jan 29;538:88-91.
2: Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on
structure, pathogenicity and immunity aspects of pandemic human coronaviruses.
Infect Genet Evol. 2020 Nov;85:104502.
3: Wang MY, Zhao R, Gao LJ, Gao XF, Wang DP, Cao JM. SARS-CoV-2: Structure,
Biology, and Structure-Based Therapeutics Development. Front Cell Infect
Microbiol. 2020 Nov 25;10:587269.
4: Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 Transmission and
Pathogenesis. Trends Immunol. 2020 Dec;41(12):1100-1115.
5: Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat
Rev Microbiol. 2021 Mar;19(3):141-154.
6: Finkel Y, Mizrahi O, Nachshon A, Weingarten-Gabbay S, Morgenstern D, Yahalom-
Ronen Y, Tamir H, Achdout H, Stein D, Israeli O, Beth-Din A, Melamed S, Weiss S,
Israely T, Paran N, Schwartz M, Stern-Ginossar N. The coding capacity of SARS-
CoV-2. Nature. 2021 Jan;589(7840):125-130.
7: Bakhiet M, Taurin S. SARS-CoV-2: Targeted managements and vaccine
development. Cytokine Growth Factor Rev. 2021 Apr;58:16-29.
8: Sanyal S. How SARS-CoV-2 (COVID-19) spreads within infected hosts – what we
know so far. Emerg Top Life Sci. 2020 Dec 11;4(4):371-378.
9: Campos DMO, Fulco UL, de Oliveira CBS, Oliveira JIN. SARS-CoV-2 virus
infection: Targets and antiviral pharmacological strategies. J Evid Based Med.
2020 Nov;13(4):255-260.
10: Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, Huang Z, Li X, Deng K, Lin B, Gao
Z. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal
swabs specimens. J Med Virol. 2020 Sep;92(9):1676-1680.
Products Related to SARS-CoV-2 Omicron Spike RBD Protein Biotinylated: Proteins
Additional Information
| Weight | 48 oz |
|---|---|
| Dimensions | 8 × 8 × 8 in |